ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,480.20
-0.36%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Eli Lilly and Co (LLY)

  7. Eli Lilly and Co (LLY) News

Eli Lilly (LLY)

Eli Lilly and Co
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:LLY
DateTimeSourceHeadlineSymbolCompany
01/06/202413:00PR Newswire (US)Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual MeetingNYSE:LLYEli Lilly and Co
31/05/202419:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
30/05/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
29/05/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
29/05/202411:00PR Newswire (US)Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseasesNYSE:LLYEli Lilly and Co
28/05/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
28/05/202415:00PR Newswire (US)Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare ConferenceNYSE:LLYEli Lilly and Co
28/05/202412:37IH Market NewsiPhone Sales Skyrocket in China, Nvidia Surges in Pre-Market Following xAI Fundraising, and More NewsNYSE:LLYEli Lilly and Co
24/05/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
24/05/202420:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
24/05/202414:30PR Newswire (US)Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline MedicinesNYSE:LLYEli Lilly and Co
23/05/202422:00PR Newswire (US)Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNYSE:LLYEli Lilly and Co
23/05/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
22/05/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
21/05/202421:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
21/05/202421:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
21/05/202421:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
21/05/202421:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
21/05/202421:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
21/05/202420:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
21/05/202413:00PR Newswire (US)More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failureNYSE:LLYEli Lilly and Co
21/05/202412:18IH Market NewsCalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils Copilot+ PCs with AI Focus, and More NewsNYSE:LLYEli Lilly and Co
16/05/202411:45PR Newswire (US)With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily InsulinNYSE:LLYEli Lilly and Co
15/05/202413:00PR Newswire (US)Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance OfficerNYSE:LLYEli Lilly and Co
09/05/202421:34Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLYEli Lilly and Co
06/05/202416:32PR Newswire (US)Lilly Declares Second-Quarter 2024 DividendNYSE:LLYEli Lilly and Co
30/04/202414:07IH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:LLYEli Lilly and Co
30/04/202412:59IH Market NewsU.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate DecisionNYSE:LLYEli Lilly and Co
30/04/202412:55IH Market NewsHSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in EarningsNYSE:LLYEli Lilly and Co
30/04/202411:45PR Newswire (US)Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline MomentumNYSE:LLYEli Lilly and Co
 Showing the most relevant articles for your search:NYSE:LLY

Your Recent History

COIN
ALQOEUR
USOTC
CRNLF
Capricorn Metals (PK)
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved